Blepharitis

Clinical Snapshot

Blepharitis is chronic inflammation of the eyelid margin — crusting, scale, and debris at the base of the eyelashes, frequently mistaken for recurrent conjunctivitis when the real problem is the eyelids, not the conjunctiva.^[1] It is classified as anterior (affecting the lash base and follicles — staphylococcal, seborrheic, or Demodex-related) or posterior (meibomian gland dysfunction, MGD — obstruction and altered secretion from the meibomian glands along the lid margin); many patients have a mixed picture. Blepharitis is a chronic, relapsing condition that is managed with ongoing lid hygiene, not cured with a single course of treatment — set this expectation with the patient from the first visit.

Recognize the Condition

The subtypes of blepharitis

Anterior blepharitis

Crusting, scale, and greasy debris at the base of the lashes; may have collarettes (cylindrical debris specifically encircling the lash base) suggesting Demodex mite involvement, missing or misdirected lashes, and recurrent styes (hordeola). Staphylococcal anterior blepharitis tends to have harder, fibrous scale with lash loss/misdirection; seborrheic anterior blepharitis tends to have greasier, softer scale and is often associated with seborrheic dermatitis elsewhere (scalp, eyebrows).

Posterior blepharitis (meibomian gland dysfunction)

Meibomian gland orifices along the lid margin become obstructed, with thickened, turbid, or absent secretion on gland expression; the tear film becomes unstable, causing evaporative dry eye symptoms — burning, foreign-body sensation, fluctuating vision. Often associated with ocular rosacea (facial flushing, telangiectasias, rhinophyma) and less itch-predominant than allergic conjunctivitis.

Demodex blepharitis

Collarettes at the lash base are the hallmark sign of Demodex mite infestation — a specific, now separately treatable subtype of anterior blepharitis (see Pharmacologic Treatment Options).

Risk Factors

Ocular or facial rosacea — strongly associated with posterior blepharitis/MGD.
Seborrheic dermatitis elsewhere (scalp, eyebrows, nasolabial folds).
Older age — both Demodex prevalence and MGD increase with age.
Contact lens wear.
Prior styes (hordeola) or chalazia.
Poor eyelid hygiene, or heavy eye makeup use without adequate removal.

Red Flags & Refer

Refer to ophthalmology for:

Any corneal involvement (photophobia, reduced vision, or a corneal opacity on exam) — chronic blepharitis/MGD can cause secondary keratitis.
A unilateral, asymmetric, or rapidly progressive lid-margin lesion, particularly with lash loss over a localized area or a firm, non-tender nodule (consider sebaceous gland carcinoma, a rare but important masquerade of chronic unilateral "blepharitis," especially in an older adult).
Suspected preseptal or orbital cellulitis (lid swelling with warmth, tenderness, fever, or pain with eye movement) rather than simple blepharitis.
Blepharitis not responding to a consistent, adequate trial of lid hygiene plus appropriate topical/oral therapy.^[2]

Assessment & Diagnosis

Differentiating bacterial, viral, and allergic conjunctivitis, and blepharitis

These four conditions are the most commonly confused causes of a red, irritated eye in community practice. Distinguishing them correctly determines whether the patient needs an antibiotic, supportive care, an antihistamine, or eyelid hygiene — and getting it wrong means either an unnecessary antibiotic or a missed diagnosis.

Bacterial conjunctivitis with diffuse conjunctival redness and purulent yellow discharge

Bacterial conjunctivitis — purulent discharge with morning crusting. (CNX OpenStax, CC BY 4.0, Wikimedia Commons)

Viral conjunctivitis with marked diffuse redness and watery discharge

Viral conjunctivitis — marked redness, watery discharge, often with a preauricular node. (Joyhill09, CC BY-SA 3.0, Wikimedia Commons)

Allergic conjunctivitis with conjunctival redness, chemosis, and eyelid swelling

Allergic conjunctivitis — itching is the dominant symptom, often with chemosis (conjunctival swelling). (James Heilman, MD, CC BY-SA 4.0, Wikimedia Commons)

Anterior blepharitis with crusting and scale at the base of the eyelashes

Blepharitis — crusting and scale at the lash base; this is an eyelid problem, not a conjunctival infection, though it can cause secondary conjunctivitis. (Imrankabirhossain, CC BY-SA 4.0, Wikimedia Commons)

Feature	Bacterial conjunctivitis	Viral conjunctivitis	Allergic conjunctivitis	Blepharitis
Laterality	Often one eye first, may spread to the other	Usually starts in one eye, spreads to the other within days	Bilateral, essentially always	Bilateral, essentially always
Discharge	Purulent, thick, yellow-green; lids stuck together on waking	Watery to mucoid; no true pus	Watery, stringy/mucoid	Greasy debris and crusting at the lash base, not a true discharge
Itching	Minimal or absent	Mild, if present	The dominant symptom — if the patient does not report itching, reconsider allergic conjunctivitis	Mild irritation/burning more than itching
Associated findings	May follow otitis media in children; no preauricular node in most cases	Preauricular lymph node, recent URTI, conjunctival membranes, subconjunctival hemorrhage	Chemosis (conjunctival swelling), lid edema, history of atopy/seasonal pattern	Lash crusting, missing/misdirected lashes, recurrent styes, meibomian gland dysfunction
Typical course	Self-limited over 1-2 weeks even without treatment; antibiotics modestly shorten this	Self-limited over 1-3 weeks; highly contagious for the first 3-7 days	Persists as long as allergen exposure continues; recurs seasonally	Chronic, relapsing; managed rather than cured
1st-line management	Often no treatment needed; a topical antibiotic modestly shortens recovery	Supportive care only — cold compresses, lubricants	Remove/avoid the allergen; topical antihistamine/mast-cell stabilizer	Lid hygiene: warm compresses plus lid margin cleansing

Distinguishing bacterial from adenoviral (viral) conjunctivitis by clinical exam alone is genuinely difficult — a point-of-care adenovirus antigen test is available in some settings and can help when the distinction changes management.

History

Chronicity and prior episodes — blepharitis is typically a long-standing, relapsing complaint, not an acute one.
Burning/irritation versus true itching (itching more prominent in allergic conjunctivitis).
Morning symptoms (crusting) versus symptoms that worsen through the day (more typical of evaporative dry eye from MGD).
History of rosacea, seborrheic dermatitis, or recurrent styes.
Contact lens wear and eye makeup habits.

Examination

Inspect the lash base for scale/crusting and specifically for collarettes (Demodex sign).
Assess lash position — missing, misdirected, or thinned lashes suggest chronic anterior blepharitis.
Express the meibomian glands (gentle digital pressure on the lower lid margin) to assess secretion quality — clear and easily expressed is normal; thick, turbid, toothpaste-like, or absent secretion suggests MGD.
Look for signs of ocular or facial rosacea.
Fluorescein staining if corneal involvement is possible.

Treatment Targets

Reduce lid margin inflammation and bacterial/Demodex load.
Restore normal meibomian gland function and tear film stability.
Prevent complications — recurrent styes, chalazia, secondary keratitis.
Set realistic expectations: control, not cure.

Choose Initial Treatment

Direct treatment rule

1st line, all blepharitis lid hygiene — warm compresses followed by lid margin cleansing — is the foundation of treatment for every subtype and must be maintained long-term, not just during a flare.

2nd line, anterior blepharitis with secondary bacterial infection a topical antibacterial ointment applied to the lid margin (not just used as eye drops) in addition to lid hygiene.

Confirmed Demodex blepharitis lotilaner ophthalmic solution, the first drug specifically approved for this indication, in addition to lid hygiene.

Moderate-to-severe posterior blepharitis/MGD low-dose oral doxycycline (anti-inflammatory dosing, not antibacterial dosing) for 1-3 months, in addition to lid hygiene and warm compresses, when topical measures alone are insufficient.^[3]

Non-Pharmacologic Treatment

Warm compresses — apply to closed lids for 5-10 minutes, 1-2 times daily; this softens debris and helps liquefy meibomian gland secretions. A reusable warming mask/device can help maintain adequate, sustained heat compared with a cooling washcloth.
Lid margin cleansing — after warm compresses, gently clean the lash base with a commercial eyelid wipe, diluted baby shampoo on a cotton swab, or a dedicated lid-hygiene product, 1-2 times daily during flares and as maintenance thereafter.
Lid massage — gentle massage along the lid margin after warm compresses helps express meibomian gland contents in posterior blepharitis/MGD.
Omega-3 fatty acid supplementation — may support meibomian gland secretion quality as an adjunct; evidence is modest but the intervention is low-risk.
Remove eye makeup thoroughly each day and replace eye makeup regularly to reduce contamination.
Set the expectation up front that this is a chronic, relapsing condition managed with ongoing hygiene, not a one-time course of treatment.

Pharmacologic Treatment Options

Drug / intervention	Role	Dose / use	Important adverse effects	Teaching points
Warm compresses + lid hygiene Preferred	1st line, all blepharitis	1-2 times daily, ongoing	None	Foundation of treatment for every subtype — must be maintained long-term.
Erythromycin ophthalmic ointment Alternative	Anterior blepharitis with secondary bacterial infection	Apply to lid margin at bedtime for 2-4 weeks	Chronic use may cause corneal toxicity, allergy, resistance	Applied to the lid margin, not just instilled as eye drops.
Fusidic acid ophthalmic Alternative	Anterior blepharitis with secondary bacterial infection	Apply to lid margin BID for 2-4 weeks	Chronic use may cause corneal toxicity, allergy	BID dosing is convenient for lid-margin application.
Lotilaner ophthalmic Special situation	Confirmed Demodex blepharitis (collarettes present)	1 drop each eye BID for 6 weeks	Instillation-site stinging/burning (~10%)	First drug specifically approved for Demodex blepharitis. Complete the full 6-week course.
Doxycycline (low-dose) Special situation	Moderate-severe posterior blepharitis/MGD, or ocular rosacea	50-100 mg PO once daily for 1-3 months	GI upset, photosensitivity	Anti-inflammatory dosing, not antibacterial dosing. Avoid in pregnancy, breastfeeding, and children under 8.
Tobramycin/dexamethasone Special situation	Severe blepharitis flare with significant inflammation	Suspension 1 drop TID-QID, or ointment TID-QID, short-term	Corneal toxicity, allergy, resistance; corticosteroid effects (may worsen herpetic/fungal keratitis, long-term glaucoma/cataracts)	Short-term only (typically ≤1-2 weeks), specialist-directed given corticosteroid component.

Special Populations

Pregnancy/breastfeeding

Lid hygiene and topical antibacterial ointments are appropriate. Avoid oral doxycycline in pregnancy and breastfeeding — it is associated with fetal/infant tooth discoloration and bone growth effects; if oral therapy for severe posterior blepharitis is truly needed, discuss alternatives with the prescriber managing the pregnancy.

Children

Avoid oral tetracyclines (including doxycycline) under 8 years of age given the risk of permanent tooth discoloration — lid hygiene and topical measures are the mainstay in this age group; a macrolide (e.g., oral azithromycin) is sometimes used instead for significant pediatric blepharitis/MGD under specialist direction.

Contact lens wearers

Blepharitis increases the risk of contact-lens-related complications (including bacterial keratitis) — reinforce hygiene and consider temporarily reducing or stopping lens wear during a flare.

Ocular rosacea

Patients with posterior blepharitis and facial rosacea benefit from co-management of the skin disease (topical/oral rosacea therapy) alongside eyelid-directed treatment — treating one without the other often gives incomplete control.

Monitoring & Follow-Up

Blepharitis is a chronic, relapsing condition managed with ongoing lid hygiene rather than cured with a single course of treatment — reinforce this at every visit. Reassess after 4-6 weeks of consistent therapy; a lack of any improvement with genuinely consistent hygiene and appropriate topical/oral therapy should prompt reconsideration of the diagnosis (or a trial of the other treatment tier — e.g., adding oral doxycycline if topical measures alone have been tried, or testing specifically for Demodex if not already assessed).

Treatment Failure / Next Step

Confirm genuine adherence to lid hygiene before assuming pharmacologic treatment failure — this is the most common reason for apparent nonresponse.
Re-examine specifically for collarettes (Demodex) if not already assessed, since lotilaner is a distinct, targeted option.^[4]
For posterior blepharitis/MGD not responding to lid hygiene and warm compresses alone, add oral low-dose doxycycline if not already trialled.
Reassess for underlying rosacea or seborrheic dermatitis driving recurrent flares, and consider dermatology co-management.
Refer to ophthalmology for any corneal involvement, an atypical or unilateral lesion (rule out sebaceous gland carcinoma), or disease genuinely refractory to combined lid hygiene, topical, and oral therapy.

Common Errors to Avoid

Treating blepharitis with a single course of antibiotic ointment and no lid-hygiene plan — without ongoing hygiene, symptoms reliably recur.
Missing Demodex as a treatable cause by not examining specifically for collarettes.
Prescribing full antibacterial-dose doxycycline for MGD when the anti-inflammatory (low) dose is what is actually indicated and better tolerated for this purpose.
Assuming chronic unilateral "blepharitis" in an older adult with progressive lash loss is simple blepharitis rather than considering sebaceous gland carcinoma, a rare masquerade.
Using a topical corticosteroid/antibiotic combination long-term without specialist supervision and monitoring for glaucoma/cataract risk.
Not addressing coexisting rosacea or seborrheic dermatitis, which drives ongoing flares if left untreated.

Clinical Decision Algorithm

Algorithm A — Red-eye triage (apply first, regardless of suspected cause)

Patient presents with a red eye

Assess for warning signs: limbal injection, corneal opacity, pain/photophobia unrelieved by anesthetic, reduced vision, pupil abnormality, trauma, contact-lens-related ulcer, or suspected chlamydial/gonococcal/herpetic/COVID-19 conjunctivitis

Any warning sign present

Refer immediately to ophthalmology (or optometry if unavailable) — do not manage as simple conjunctivitis or blepharitis

No warning signs

Proceed to condition-specific assessment and management

Algorithm B — Blepharitis assessment and management

Chronic lid margin crusting/irritation; no acute red flags

Examine lash base for collarettes; express meibomian glands to assess secretion quality

Collarettes present

Demodex blepharitis: lid hygiene + lotilaner ophthalmic BID x 6 weeks

Thick/turbid or absent meibomian secretion, minimal collarettes

Posterior blepharitis/MGD: lid hygiene + warm compresses + lid massage; add low-dose oral doxycycline if moderate-severe or not responding

Lash-base crusting without collarettes, normal meibomian secretion

Anterior (staphylococcal/seborrheic) blepharitis: lid hygiene ± topical antibacterial ointment to the lid margin

Corneal involvement, unilateral/atypical lesion, or no improvement after consistent therapy: refer to ophthalmology

Drug Tables

How to use this table: Doses are adult doses and require patient-specific confirmation (renal/hepatic function, weight, allergy history). Pediatric dosing is weight-based per the current product monograph unless stated. Drug pricing is intentionally omitted. Select any drug name to open its complete Pharmasist Drug Database page.

Lid hygiene (warm compresses + lid margin cleansing) is the foundation of every regimen below — none of these drugs replace it, and most flare again if hygiene is not maintained long-term.

Topical antibacterials — lid margin application

Applied directly to the lid margin (not just instilled as drops) for anterior blepharitis with secondary bacterial infection.

Drug	Dosage	Adverse effects	Comments
Erythromycin ophthalmic ointment	All ages: Apply to lid margin at bedtime for 2-4 weeks	Chronic use may cause corneal epithelial toxicity, allergy, resistance	Apply a small amount to the lid margin, not into the eye itself, using a clean fingertip or cotton swab.
Fusidic acid ophthalmic	All ages: Apply to lid margin BID for 2-4 weeks	Chronic use may cause corneal toxicity, allergy	BID dosing convenient for lid-margin application.

Demodex-targeted therapy

For confirmed Demodex blepharitis (collarettes present at the lash base).

Drug	Dosage	Adverse effects	Comments
Lotilaner ophthalmic solution	All ages: 1 drop each eye BID for 6 weeks	Instillation-site stinging/burning (~10%); rare chalazion/hordeolum, punctate keratitis	First drug specifically FDA-approved for Demodex blepharitis (2023). Complete the full 6-week course even if collarettes improve earlier.

Oral therapy for posterior blepharitis/meibomian gland dysfunction

Anti-inflammatory (low) dosing, not antibacterial dosing — a different regimen from treating a systemic infection.

Drug	Dosage	Adverse effects	Comments
Doxycycline (low-dose)	Adults: 50-100 mg PO once daily	GI upset, photosensitivity, rare esophageal irritation	1-3 month course; longer in rosacea-associated disease. Avoid in pregnancy, breastfeeding, and children under 8 years (tooth discoloration).

Topical antibacterial/corticosteroid combination

Short-term only, specialist-directed, for a significant inflammatory flare — corticosteroid component carries real long-term risk (glaucoma, cataracts) and may worsen undiagnosed herpetic/fungal disease.

Drug	Dosage	Adverse effects	Comments
Tobramycin/dexamethasone	All ages: Suspension 1 drop TID-QID, or ointment TID-QID, short-term	Corneal toxicity, allergy, resistance; corticosteroid effects (stinging, may worsen herpetic/fungal keratitis, long-term glaucoma/cataracts)	Severe blepharitis, rosacea-associated eyelid disease.
Neomycin/polymyxin B/dexamethasone	All ages: Suspension 1 drop TID-QID, or ointment TID-QID, short-term	Corneal toxicity, allergy, resistance; corticosteroid effects	Same indications and cautions as tobramycin/dexamethasone.

References

Blepharitis Preferred Practice Pattern — Ophthalmology, American Academy of Ophthalmology (Lin A, Rhee MK, Akpek EK, et al.). Ophthalmology 2024;131(4):P54-P127
Bedside diagnosis of the 'red eye': a systematic review — American Journal of Medicine (Narayana S, McGee S). Am J Med 2015;128(11):1220-1224
The role of oral doxycycline in meibomian gland dysfunction — Cornea/Ocular Surface literature (summarized in Blepharitis PPP evidence base). See Blepharitis PPP, Ophthalmology 2024;131(4)
Advances in the treatment of Demodex blepharitis: strategies for improving patient outcomes — American Journal of Managed Care. AJMC, 2024

Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.